Wellness AI or Medical Device? Why Intended Use Changes What a Health Tool Can Claim

The Question Hidden Behind the Interface

AI health tools increasingly turn steps, sleep, heart rate, glucose, nutrition, labs, and symptoms into recommendations. The interface may look polished, but the most important question is often hidden: What is the tool intended to do?

In January 2026, the U.S. Food and Drug Administration finalized updated guidance on low-risk general wellness products. The guidance clarifies that software intended to encourage a healthy lifestyle, unrelated to diagnosis or treatment, may fall outside the medical-device definition. When a product claims to detect disease, guide treatment, or perform another medical function, different regulatory and evidence expectations may apply.

This boundary matters to consumers, clinics, and wellness companies because a helpful coaching suggestion is not the same as a validated medical conclusion.

The Same Data Can Support Different Claims

Consider resting heart-rate data from a wearable. A wellness app might encourage a user to review sleep, stress, hydration, and recent training after an unusual trend. Another system might claim that the same pattern detects atrial fibrillation or predicts a cardiac event.

The first use may be general wellness. The second is a medical claim that requires appropriate evidence and regulatory consideration. The algorithm can be similar, but the purpose and consequence differ.

The same is true for glucose. A tool may help a generally healthy person observe how meals relate to sensor readings. If it recommends insulin dosing or claims to diagnose diabetes, the risk is substantially higher.

What FDA's General Wellness Guidance Says

FDA's 2026 guidance addresses low-risk products that promote a healthy lifestyle. Examples can relate to weight management, physical fitness, relaxation, sleep, sexual function, cognitive performance, and other general wellness goals, provided the claims stay within the policy's boundaries.

Software functions intended for maintaining or encouraging a healthy lifestyle and unrelated to diagnosis, cure, mitigation, prevention, or treatment of disease may be excluded from the device definition under federal law. The exact language and product functionality matter.

A disclaimer cannot magically convert a diagnostic system into a wellness tool. Regulators consider intended use as shown by labeling, advertising, user instructions, design, and circumstances of distribution. Consumers should therefore read beyond “for wellness only” and examine what the product actually promises.

FDA Authorization Is Specific

FDA maintains resources for digital health and AI-enabled medical devices. Inclusion or authorization does not mean an algorithm is correct for every patient, setting, wearable, or purpose. It means the agency evaluated a defined product for a defined intended use through an applicable pathway.

An app can contain multiple functions. Some may be regulated while others are not. Updates can also change performance. An authorization for one version, population, or input should not be generalized to every future feature.

Ask for the exact product name, intended use, target population, required device, and authorization status. Phrases such as FDA registered, FDA compliant, or built with FDA-listed components are not the same as an authorized medical claim.

Personalized Does Not Mean Proven

AI can tailor outputs using age, genetics, labs, wearable trends, preferences, and prior behavior. That may make guidance more relevant. It can also create an illusion of precision.

A recommendation can be highly personalized and still be wrong. The training data may underrepresent certain ancestries, ages, health conditions, or device types. Sensor errors can feed the model. Correlation can be mistaken for cause. A system may confidently explain normal variation as a meaningful event.

Personalization should therefore be evaluated on several levels: analytical accuracy, clinical validity when medical claims are made, usefulness, fairness across groups, transparency, and real-world outcomes.

The Importance of Intended Audience

Advice that is reasonable for a healthy adult may be unsafe for a person with diabetes, kidney disease, an eating disorder, pregnancy, frailty, or multiple medications. Good systems define who should and should not use the product.

They also recognize escalation boundaries. A wellness tool should not reassure someone with emergency symptoms or delay appropriate medical care. It should clearly distinguish educational information from clinician-reviewed decisions.

Uncertainty Should Be Visible

Many AI interfaces produce a single score because it is easy to understand. A recovery score of 72 looks exact, even if it combines noisy sensor data, a proprietary model, and incomplete sleep detection.

Useful systems explain what changed, which data contributed, whether information is missing, and how confident the model is. They avoid turning small daily fluctuations into urgent recommendations. Trends, ranges, and baseline comparisons are often more honest than a precise point estimate.

NIST's AI Risk Management Framework describes trustworthy AI characteristics such as validity, reliability, safety, transparency, explainability, privacy enhancement, and fairness with bias managed. These qualities are relevant even when a product is not regulated as a medical device.

Data Quality Comes Before Intelligence

Wearables can lose contact, misclassify exercise, estimate sleep incorrectly, or shift after a firmware update. Laboratory values can vary by timing, hydration, acute illness, and assay. Food logs are incomplete. Genetic reports may omit relevant variants.

AI cannot repair every weakness in its inputs. Sometimes it amplifies them. A strong system checks for missingness, implausible readings, sensor changes, and conflicts between data sources. It should also allow users and professionals to correct obvious errors.

Privacy and Secondary Use

Personalized wellness requires personal data. Users should know what is collected, how long it is retained, whether it is used to train models, whether it is sold or shared, and how deletion or export works.

Health data held by a consumer wellness company may not have the same protections as information held by a healthcare provider under HIPAA. Privacy policies can be difficult to read, but vague assurances such as bank-level security do not answer questions about secondary use or governance.

WHO guidance on AI for health emphasizes autonomy, safety, transparency, accountability, equity, and sustainability. Those principles apply to the entire lifecycle, not only the algorithm.

What Partner Clinics Should Ask

Clinics evaluating an AI wellness platform should define the intended use and workflow. Who reviews alerts? What happens after an abnormal result? How was the system validated? Which groups were included? Can performance be monitored after deployment? How are updates controlled?

A tool that creates more false alarms can increase workload and anxiety. A tool that suppresses uncertainty can create false reassurance. The right metric is not engagement alone. It is whether the system improves a meaningful process or outcome without unacceptable harm.

Clinics should also avoid allowing marketing language to outrun evidence. A platform can support organization, education, and pattern recognition without claiming to diagnose, treat, or replace clinicians.

How CoGenetix Fits

CoGenetix positions AI as part of a precision-wellness ecosystem that connects genetics, labs, nutrition, metabolic information, and longitudinal monitoring. The appropriate role is to help organize complex data, surface patterns, and support better questions.

Human oversight remains essential. AI-generated wellness insights should be interpreted according to their intended use, evidence, uncertainty, and the person's health context. Clinical decisions belong with qualified healthcare professionals.

A Consumer Checklist

Ask what the product claims to do and what it explicitly does not do. Determine whether it is general wellness software or whether a specific medical function is FDA authorized. Ask which data sources it uses, how it handles missing data, and whether performance has been studied in people like you.

Review privacy and model-training policies. Look for explanations, not just scores. Confirm whether a clinician reviews important outputs. Finally, ask what action the recommendation supports and what could happen if it is wrong.

The Bottom Line

AI can make wellness data more usable, but the label “personalized” does not establish medical validity. Intended use separates coaching from diagnosis, and that boundary changes the evidence, oversight, and risk that should be expected.

The most trustworthy tools are clear about what they know, what they do not know, and when a qualified human must take over.

Key Takeaways

Intended use, not merely the technology, helps determine whether software is a wellness product or a medical device. A sleep or activity insight can be low risk, while a diagnosis or treatment recommendation carries higher stakes. FDA authorization applies to a specific product and intended use, not to AI as a category. Personalization does not guarantee accuracy, fairness, or clinical benefit. Good systems communicate uncertainty, protect data, and keep qualified humans involved.